Imara
IPOPublic · Boston, United States · Founded 2016 · $94.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- imarainc.com
- Total Funding
- $94.0M
- Last Round
- $63.0M Series BMar 2019
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Imara Inc. was a Boston-based clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for sickle cell disease and beta-thalassemia. Founded in 2016, Imara advanced its lead candidate tovinontrine through clinical trials before discontinuing the program in 2022. The company subsequently completed a reverse merger with Enliven Therapeutics in February 2023.
Summary
Imara is a Biotech company based in Boston, United States, founded in 2016. It has raised $94.0M in total across 2 rounds, most recently a $63.0M Series B round in Mar 2019. Investors include OrbiMed, Arix Bioscience and New Enterprise Associates.
Funding History
Mar 2019
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imara"><img src="https://indexed.vc/api/badge/company/imara" alt="Imara on Indexed.vc" width="260" height="76" /></a>